Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Orally bioavailable LTD4 antagonists from Menarini

Sep. 27, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Novel antiemetic/gastric prokinetic agent from Dainippon

Sep. 27, 1996

New anxiolytic from SmithKline Beecham

Sep. 27, 1996

Hypocholesterolemic and hypocholesterolemic/antioxidant compounds from Pierre Fabre

Sep. 27, 1996

Immunosuppressant oligopeptide from Italfarmaco

Sep. 27, 1996

Development of COX-2 inhibitors at Searle

Sep. 27, 1996

Ciba characterizes another novel HIV protease inhibitor

Sep. 27, 1996

Novel class of HIV protease inhibitors with improved activity

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...